Psybio Therapeutics Corp Stock Working Capital
| PSYBF Stock | USD 0.0001 0.00 0.00% |
PsyBio Therapeutics Corp fundamentals help investors to digest information that contributes to PsyBio Therapeutics' financial success or failures. It also enables traders to predict the movement of PsyBio Pink Sheet. The fundamental analysis module provides a way to measure PsyBio Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PsyBio Therapeutics pink sheet.
PsyBio |
PsyBio Therapeutics Corp Company Working Capital Analysis
PsyBio Therapeutics' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Based on the company's disclosures, PsyBio Therapeutics Corp has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The working capital for all United States stocks is 100.0% higher than that of the company.
PsyBio Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PsyBio Therapeutics' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PsyBio Therapeutics could also be used in its relative valuation, which is a method of valuing PsyBio Therapeutics by comparing valuation metrics of similar companies.PsyBio Therapeutics is currently under evaluation in working capital category among its peers.
PsyBio Fundamentals
| Return On Equity | -3.1 | |||
| Return On Asset | -0.98 | |||
| Current Valuation | 3.69 M | |||
| Shares Outstanding | 80.85 M | |||
| Shares Owned By Insiders | 25.61 % | |||
| Shares Owned By Institutions | 13.23 % | |||
| Price To Book | 202.42 X | |||
| Gross Profit | (1.56 M) | |||
| EBITDA | (10.91 M) | |||
| Net Income | (11.02 M) | |||
| Cash And Equivalents | 911.83 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 207.81 K | |||
| Debt To Equity | 7.03 % | |||
| Current Ratio | 0.89 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (6.95 M) | |||
| Earnings Per Share | (0.09) X | |||
| Market Capitalization | 4.94 M | |||
| Total Asset | 4.01 M | |||
| Z Score | 7.2 | |||
| Net Asset | 4.01 M |
About PsyBio Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PsyBio Therapeutics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PsyBio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PsyBio Therapeutics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in PsyBio Pink Sheet
PsyBio Therapeutics financial ratios help investors to determine whether PsyBio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PsyBio with respect to the benefits of owning PsyBio Therapeutics security.